[Acute and chronic heart failure in light of the new ESC guidelines].

about

[New pharmaceuticals in cardiology. Heart failure, anticoagulation, dyslipidemia].

P2860

Q48752264-92B0D8A6-2700-413B-97BF-B8BD81A2AFC4

P2860

[Acute and chronic heart failure in light of the new ESC guidelines].

Item

http://www.wikidata.org/entity/Q54716857

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

[Acute and chronic heart failure in light of the new ESC guidelines].

@en

[Acute and chronic heart failure in light of the new ESC guidelines].

@nl

type

Item

label

[Acute and chronic heart failure in light of the new ESC guidelines].

@en

[Acute and chronic heart failure in light of the new ESC guidelines].

@nl

prefLabel

[Acute and chronic heart failure in light of the new ESC guidelines].

@en

[Acute and chronic heart failure in light of the new ESC guidelines].

@nl

P1476

[Acute and chronic heart failure in light of the new ESC guidelines].

@en

P2093

A Link

http://www.w3.org/2001/XMLSchema#string

J Pöss

http://www.w3.org/2001/XMLSchema#string

M Böhm

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal vasodilation in pregnancy: the emerging role of relaxin

Effect of nesiritide in patients with acute decompensated heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Eplerenone is not superior to older and less expensive aldosterone antagonists

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.

P304

812-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00059-013-3986-9

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24146139

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

[Acute and chronic heart failure in light of the new ESC guidelines].

about

P2860

P2860

[Acute and chronic heart failure in light of the new ESC guidelines].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921